Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T05:05:45.605Z Has data issue: false hasContentIssue false
  • English
  • Français

Late effects of radiofrequency ablation lesions resulting in a progressive mitral valve perforation in a 2-month-old infant

Part of: Electrophysiology

Published online by Cambridge University Press:  02 September 2019

Feng Wang Open the ORCID record for Feng Wang [Opens in a new window] ,
Gang Chen  and
Lin Wu Open the ORCID record for Lin Wu [Opens in a new window]
Feng Wang
Affiliation:
Department of Cardiology, Cardiovascular Center, Children’s Hospital of Fudan University, Shanghai, China
Gang Chen
Affiliation:
Department of Cardiology, Shanghai First People’s Hospital affiliated to Jiaotong University, Shanghai, China
Lin Wu*
Affiliation:
Department of Cardiology, Cardiovascular Center, Children’s Hospital of Fudan University, Shanghai, China
*
Author for correspondence: L. Wu, Department of Cardiology, Cardiovascular Center, Children’s Hospital of Fudan University, 399 Wanyuan Road, Shanghai 201102, China. Tel: +86-21-6493-2800; Fax: +86-21-6493-1901; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

There has been great concern with the use of radiofrequency ablation in infants since radiofrequency ablation lesions were shown to have a progressing nature in immature myocardium of animals. In this report, we present a 2-month-old infant with life-threatening medically refractory supraventricular tachycardia. Radiofrequency ablation successfully cured arrhythmia; however, late effects of radiofrequency ablation lesions resulted in a progressive mitral valve perforation requiring surgical repair.

Keywords

Catheter ablationsupraventricular tachycardiamitral valvecomplicationsinfant
Type
Brief Report
Information
Cardiology in the Young , Volume 29 , Issue 10 , October 2019 , pp. 1297 - 1299
Check for updates
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Khairy, P, Guerra, PG, Rivard, L, et al. Enlargement of catheter ablation lesions in infant hearts with cryothermal versus radiofrequency energy: an animal study. Circ Arrhythm Electrophysiol 2011; 4: 211–217.CrossRefGoogle Scholar
Saul, JP, Hulse, JE, Papagiannis, J, Van Praagh, R, Walsh, EP. Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation 1994; 90: 492–499.CrossRefGoogle ScholarPubMed
Akdeniz, C, Ergul, Y, Kiplapinar, N, Tuzcu, V. Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants. Cardiol J 2013; 20: 241–246.CrossRefGoogle ScholarPubMed
Svintsova, LI, Popov, SV, Kovalev, IA. Radiofrequency ablation of drug-refractory arrhythmias in small children younger than 1 year of age: single-center experience. Pediatr Cardiol 2013; 34: 1321–1329.CrossRefGoogle ScholarPubMed
Ozaki, N, Nakamura, Y, Suzuki, T, et al. Safety and efficacy of radiofrequency catheter ablation for tachyarrhythmia in children weighing less than 10 kg. Pediatr Cardiol 2018; 39: 384–389.CrossRefGoogle ScholarPubMed
Avitall, B, Helms, RW. Determinants of radiofrequency-induced lesion size. In: Huang, SKS, Wilber, DJ (eds). Radiofrequency Catheter Ablation of Cardiac Arrhythmias. Futura Publishing, Armonk, NY, 2000: 47–80.Google Scholar
Blaufox, AD, Paul, T, Saul, JP. Radiofrequency catheter ablation in small children: relationship of complications to application dose. Pacing Clin Electrophysiol 2004; 27: 224–229.CrossRefGoogle ScholarPubMed
Philip Saul, J, Kanter, RJ, Writing, C, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm 2016; 13: e251–e289.CrossRefGoogle Scholar
Brugada, J, Blom, N, Sarquella-Brugada, G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 2013; 15: 1337–1382.CrossRefGoogle Scholar